Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis

CARMEN GALÁN SOLDEVILLA2026-01-292026-01-29201710.1111/all.130922-s2.0-85011615064https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27844ImmunologyImmunology and AllergyImmunologyImmunology and AllergyDefining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis – an EAACI position paperresearch article